EWTX : Insider Transactions for Edgewise Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Edgewise Therapeutics, Inc. (EWTX)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

92,270,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe, rare muscle disorders. Co.'s primary product candidate, EDG-5506, is an orally administered allosteric, selective, fast myofiber (type II) myosin small molecule inhibitor designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. Using its proprietary drug discovery platform, Co. is developing a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a range of genetically defined muscle disorders.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	919,947	919,947	2,649,435
Total Buy Value	$0	$10,100,948	$10,100,948	$27,090,905
Total People Bought	0	3	3	4
Total Buy Transactions	0	3	3	8
Total Shares Sold	14,241	325,158	325,158	545,822
Total Sell Value	$269,297	$4,185,436	$4,185,436	$5,738,880
Total People Sold	6	6	6	6
Total Sell Transactions	6	15	15	39
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 117

Page 4 of 5

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

General Counsel

• – –

2021-12-28

4

OE

$0.71

$3,834

D/D

5,400

6,962

-

Chief Scientific Officer

• • –

2021-11-15

4

AS

$19.07

$9,155

D/D

(479)

0

-

Chief Scientific Officer

• • –

2021-11-12

4

AS

$19.51

$167,074

D/D

(8,562)

479

-

Chief Scientific Officer

• • –

2021-11-11

4

AS

$19.82

$384,238

D/D

(19,276)

9,041

-

Chief Scientific Officer

• • –

2021-11-10

4

AS

$19.70

$243,170

D/D

(12,326)

28,317

-

Chief Scientific Officer

• • –

2021-11-09

4

AS

$19.94

$594,306

D/D

(29,576)

40,643

-

Chief Scientific Officer

• • –

2021-11-08

4

AS

$20.16

$181,824

D/D

(9,017)

70,219

-

Chief Scientific Officer

• • –

2021-11-05

4

AS

$19.62

$255,907

D/D

(13,042)

79,236

-

Chief Scientific Officer

• • –

2021-11-04

4

AS

$19.76

$146,092

D/D

(7,392)

92,278

-

Chief Scientific Officer

• • –

2021-11-03

4

AS

$17.98

$476,096

D/D

(26,184)

99,670

-

Chief Scientific Officer

• • –

2021-11-02

4

AS

$17.43

$305,360

D/D

(17,519)

125,854

-

Chief Scientific Officer

• • –

2021-11-01

4

AS

$18.02

$8,454

D/D

(469)

143,373

-

Chief Scientific Officer

• • –

2021-10-15

4

AS

$18.00

$25,966

D/D

(1,433)

143,842

-

Chief Scientific Officer

• • –

2021-10-14

4

AS

$18.18

$104,517

D/D

(5,749)

145,275

-

Chief Scientific Officer

• • –

2021-10-11

4

AS

$18.02

$22,885

D/D

(1,270)

151,024

-

Chief Scientific Officer

• • –

2021-10-08

4

AS

$18.15

$107,121

D/D

(5,902)

152,294

-

Chief Scientific Officer

• • –

2021-10-07

4

AS

$18.56

$241,614

D/D

(13,018)

158,196

-

Chief Scientific Officer

• • –

2021-10-06

4

AS

$18.03

$38,007

D/D

(2,108)

171,214

-

Chief Scientific Officer

• • –

2021-10-05

4

S

$18.26

$98,677

D/D

(5,404)

173,322

-

Chief Scientific Officer

• • –

2021-10-04

4

S

$18.00

$1,800

D/D

(100)

178,726

-

Chief Scientific Officer

• • –

2021-10-01

4

S

$18.00

$4,932

D/D

(274)

178,826

-

Chief Scientific Officer

• • –

2021-09-29

4

AS

$16.83

$199,730

D/D

(11,844)

179,100

-

Chief Scientific Officer

• • –

2021-09-28

4

AS

$17.30

$252,753

D/D

(14,610)

190,944

-

Chief Scientific Officer

• • –

2021-09-27

4

AS

$17.98

$208,774

D/D

(11,611)

205,554

-

Chief Scientific Officer

• • –

2021-09-24

4

AS

$18.16

$365,016

D/D

(20,100)

217,165

-

117 Records found	1 2 3 4 5	Page 4 of 5

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.